These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20259493)
1. [On the therapeutic utility of emetin against nonspecific pyogenic infections]. MELCHIOR E Ars Med; 1947; 37(5):299-304. PubMed ID: 20259493 [No Abstract] [Full Text] [Related]
2. [Emetin, a therapeutic agent against non-specific septic infections]. MELCHIOR E Wien Klin Wochenschr; 1949 Sep; 61(35-36):581-4. PubMed ID: 18142124 [No Abstract] [Full Text] [Related]
3. [Therapy of appendicular thrombophlebitis mesaraica with emetin]. MELCHIOR E Schweiz Med Wochenschr; 1949 Jul; 79(29):673-5. PubMed ID: 18137556 [No Abstract] [Full Text] [Related]
4. [Emetin and appendicitis]. MELCHIOR E Helv Chir Acta; 1949 May; 16(2):126-50. PubMed ID: 18130303 [No Abstract] [Full Text] [Related]
5. [Synthesis and amoebicid properties of emetin analogs. Analysis of the new compounds by 13C-NMR. B/C-cis or trans-fused (+/-) 1-alkyl-3-desethyl-emetin (author's transl)]. Buzas A; Cavier R; Cossais F; Finet JP; Jacquet JP; Lavielle G; Platzer N Helv Chim Acta; 1977 Nov; 60(7):2122-34. PubMed ID: 200588 [No Abstract] [Full Text] [Related]
6. [Comparative study of emetin and conessin in the treatment of amebiasis]. SIGUIER F; PIETTE M; CROSNIER J Maroc Med; 1949 Jun; 28(289):300-9. PubMed ID: 18135030 [No Abstract] [Full Text] [Related]
7. Distribution of emetine in tissues. PARMER LG; COTTRILL CW J Lab Clin Med; 1949 Jun; 34(6):818-21. PubMed ID: 18151320 [No Abstract] [Full Text] [Related]
8. Further evidence regarding the structure of emetine. BATTERSBY AR; OPENSHAW HT Experientia; 1949 Oct; 5(10):398. PubMed ID: 18149076 [No Abstract] [Full Text] [Related]
9. Nature of the action of emetine upon Entamoeba histolytica. STEWART GT Nature; 1949 May; 163(4152):842. PubMed ID: 18129706 [No Abstract] [Full Text] [Related]
10. Emetine in purulent infections. PREISS K; TURK G Harefuah; 1950 Apr; 38(8):126. PubMed ID: 15414991 [No Abstract] [Full Text] [Related]
11. Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor. Kakiuchi T; Watanabe M; Hozumi N; Nariuchi H J Immunol; 1990 Sep; 145(6):1653-8. PubMed ID: 2391415 [TBL] [Abstract][Full Text] [Related]
12. Preliminary experimental and clinical results with a new synthetic emetine-like compound. HERRERO J; BROSSI A; FAUST M; FREY JR Ann Biochem Exp Med; 1960; 20(Suppl)():475-80. PubMed ID: 13906816 [No Abstract] [Full Text] [Related]
13. [Comparison of the rate of elimination of racemic 2-dehydroemetine (Ro 1-9334) and of natural emetine in animals]. SCHWARTZ DE; RIEDER J Bull Soc Pathol Exot Filiales; 1961; 54():38-48. PubMed ID: 13749080 [No Abstract] [Full Text] [Related]
14. [Emetin in the therapy of severe surgical infections]. MELCHIOR E Zentralbl Chir; 1952; 77(10):401-7. PubMed ID: 14951861 [No Abstract] [Full Text] [Related]
15. [Azotized emetine analogues: synthesis and evaluation of the anti-amebic and anti-tumoral action of aza-3 emetine and attempted synthesis of aza-2 emetine]. Gilbert J; Gansser C; Viel C; Cavier R; Chenu E; Hayat M Farmaco Sci; 1978 Apr; 33(4):237-52. PubMed ID: 216576 [TBL] [Abstract][Full Text] [Related]